World Health Summit 2009

October 14-18, 2009


Everyone’s wish is to become and stay healthy. While medical research has already made major advances in disease prevention, diagnosis and therapy, many questions remain unanswered, and constant changes in living and environmental conditions give rise to new issues. For example, along with the ageing of society, the increasing frequency of “lifestyle diseases” such as diabetes, heart problems, circulatory ailments and rheumatism pose new challenges to health care.

These changes lead to a number of questions: How can successful prevention be ensured from childhood onwards? What innovative therapies and strategies exist to combat epidemics and new health risks? How can we fund medical progress, and what forms should national health systems take? In a globalized world these issues no longer respect national borders. If we want to seek and find good and stable solutions, it is clear that we can only do so together rather than in isolation.

For this reason I am very pleased that this year, for the first time, the Charité – Universitätsmedizin Berlin, together with the Université Paris Descartes and other international partners, are holding the World Health Summit in Berlin. For five days numerous experts and guests from around the world will discuss current and future challenges facing medicine and health care. I wish everyone, including the organizers, an informative and successful conference.

Angela Merkel
Chancellor of the Federal Republic of Germany

Europe is facing new geopolitical realities. The challenges in the fields of energy supply, climatic change, innovation and health care, if dealt with appropriately, will allow Europe to sustain its global competitiveness. In light of these trends and changes, it is necessary to create ideal conditions to facilitate joint discussions towards developing and offering aligned political, economic and scientific solutions for the well-being of the European citizens.

The World Health Summit organised by the Charité – Universitätsmedizin Berlin in cooperation with the Université Paris Descartes is a perfect example of what Europe needs. It offers necessary elements ensuring its appeal and influence in the medical world and beyond. The World Health Summit is part of the “M8-Alliance”, a group of internationally prestigious medical faculties. This initiative represents an opportunity to bring together politicians, public and private decision-makers dedicated to the health of our citizens.

For me personally it is a pleasure to support the Charité – Universitätsmedizin Berlin and the Université Paris Descartes in organising and coordinating such an event. I wish the World Health Summit global success. The World Health Summit confirms the commitment of France and Germany to Europe in accordance with the Lisbon Strategy.

Nicolas Sarkozy
President of the French Republic

Track Information 2009

The World Health Summit 2009 program was organized by four tracks and their sub-topics:

Infectious diseases
•    Good International Cooperation Is Decisive in Protecting Against Pandemics
•    Climate Change: Challenge for Healthcare
•    Berlin Declaration on Tuberculosis: High Level Follow-up of High Priority Countries for TB Control in the WHO-Euro Region
•    Humanitarian Medicine: A Concern Of The University

Health Care Across the Generations

•    Prevention of Childhood Risk Factors for Chronic Adult Diseases
•    Aging Populations
•    Evolutionary Medicine
•    Diabetes- the Global Problem
•    Personalized Medicine: Prevention and Treatment

Health Systems
•    Socio- Economic Transition: Health Care Consequences
•    New Technologies in Diagnostics and Treatment of Socially Significant Children’s Disease
•    How to Reimburse Innovations in Regenerative Medicine?
•    Improving Research Conditions for Young Scientists

Adapting the Research Agenda
•    Can We Cope With Medical Progress?
•    Clinical Trials: Innovation, Regulation and Cost
•    Patients Needs and Health Research

Speakers 2009

Ion Ababii
State Medical and Pharmaceutical University

Mamed Dz. Aliev
Director Pediatric Oncology Institute
Russian Cancer Research Center

Timothy Allsopp
Pfizer Regenerative Medicine

Margaret Alston
Faculty of Medicine Nursing & Health Sciences, Monash University

Gerard Anderson
Professor, Health Policy and Management
Johns Hopkins Bloomberg School of Public Health

Joseph Antos
Wilson H. Taylor Scholar in Health Care and Retirement Policy
American Enterprise Institute

Rifat Atun
The Global Fund to Fight AIDS, Tuberculosis and Malaria

Hans A. Aukes
Senior Executive Vice President Innovations
Deutsche Telekom AG

Roselyne Bachelot
Ministry of Health, France

Christopher Baethge
Chief Editor Section Science and Medicine
Deutsches Ärzteblatt

Alexander Baranov
Scientific Center of Children’s Health

Andreas Barner
Chairman of the Board of Managing Directors
Boehringer Ingelheim GmbH

Kathleen Barnes
Department of Medicine
Johns Hopkins University

Jörg Baumann
Fraunhofer Institute for Cell Therapy and Immunology

Ulrike Beisiegel
Director Institut for Bicohemistry
University Medical Center Hamburg-Eppendorf

Gillian Bentley
Professor of Anthropology
Durham University

Patrick Berche
Dean Medicine Faculty
Université Paris Descartes

Håkan Billig
Secretary General of Medicine
The Swedish Research Council, Gothenburg University

Sara Bleich
Assistant Professor, Health Policy and Management
Johns Hopkins Bloomberg School of Public Health

Michael Böhm
Department of Cardiology, Angiology and Intensive Care, University Hospital Saarland

Laurent Bonnardot
Laboratoire d’Ethique Médicale et de Médecine Légale

Martin Borggrefe
Department of Cardiology, Angiology, Pneumology, Intensive Care and Clinical Haemostaseology, University Hospital Mannheim

Charles Boult
Lipitz Professor of Health Policy and Management
Johns Hopkins Bloomberg School of Public Health

Richard Boyd
Director, Monash Immunology & Stem Cell Laboratories
Monash University

Joel Breman
Senior Scientific Advisor
Fogarty International Center, National Institutes of Health

Pamela Briggs
Dean and Director of the Psychology and Communications Technology (PACT) Lab
Northumbria University, School of Psychology and Sport Sciences

Martin Brüne
Professor of Psychiatry
University of Bochum

Bernhard Bührlen
Head of Business Unit ’Innovations in the Health System’
Fraunhofer Institute for Systems and Innovation Research

Reinhard Busse
Professor for Health Care Management
Technische Universität Berlin

Shing Chang
DNDi R&D Director
DNDi Drugs for Neglected Diseases

Jorgo Chatzimarkakis
European Parliament

Caroline Claude
Medical Student, in charge of international affairs, AMPC
Université Paris Descartes

Jean-Francois Clervoy
European Space Agency

Rita Colwell
Distinguished University Professor
University of Maryland

Allan Cumming
Professor of Medical Education
University of Edinburgh

Volker Damann
European Astronaut Center

Marc Danzon
Regional Director
WHO Regional Office for Europe

Stephan Davies
Chief Operating Officer
Cambridge University Health Partners

Jeffrey R. Davis
NASA, Space Life Sciences

Mikhail Ivanovich Davydov
Russian Academy of Medical Sciences

David de Kretser
Governor of Victoria, Emeritus Professor
Monash University

Guy de Thé
Inter Academy Medical Panel

John E. Deanfield
Chair of Congenital Heart Disease
UCL ICH Great Ormond Street Hospital London

Laurent Degos
Chairman of the Board
French National Authority for Health

Amelie Deister
20th European Students' Conference (ESC)

Alain Deloche de Moyelle
La Chaîne de l’Espoir

Catherine Denis
Head of the Dept. for Medical Devices Assessment

Karl-Matthias Deppermann
Helios-Clinic Erfurt

Michaela Dewes
20th European Students' Conference (ESC)

Manfred Dietel
Director Institute of Pathology
Charité - Universitätsmedizin Berlin

Stefanie Dimmeler
J.W. Goethe University Hospital and Faculty of Medicine

Ludger Dinkelborg
Head of Diagnostic Imaging Research
Bayer Schering Pharma AG

Ulrich Dirnagl
Director CSB and PI BCRT
Charite - Universitätsmedizin Berlin

Carl Djerassi
Professor of Chemistry (Emeritus)
Stanford University

Jean-Jacques Dordain
Director General
European Space Agency

Alan Downey
Global Head of KPMG's Health Care practice
KPMG in the UK

Ruxandra Draghia-Akli
Health Directorate DG Research, European Commission

Lisa C. Dubay
Associate Professor
Health Policy and Management, Johns Hopkins Bloomberg School of Public Health

Georg Duda
Vice Director Berlin-Brandenburg Center for Regenerative Therapies and Director
Julius-Wolff-Institute and Center for Muskuloskeletal Surgery, Charité- Universitätsmedizin Berlin

Michelle Dunstone
Monash University

Kristie Ebi
Executive Director, WGII TSU
Intergovernmental Panel on Climate Change

Martin Ebinger
Center for Stroke Research Berlin (CSB) - Charité – Universitätsmedizin Berlin

Bernhard Egger
Head of the Medical Department
GKV-Central Association

Tilman Ehrbeck
McKinsey & Company, Inc.

Karl Max Einhäupl
Charité - Universitätsmedizin Berlin

Karl Ekdahl
Head of Health Communication Unit
European Centre for Diesease Prevention and Control

Paul Elliott
Director, MRC-HPA Centre for Environment and Health
Imperial College London

Frank Emmrich
Fraunhofer Institute for Cell Therapy and Immunology

Liang En Wee
Yong Loo Lin School of Medicine, National University of Singapore

Gina Eom
Charité Medical University

Jean-Yves Fagon
Director Politique Medicale
Assistance Publique-Hopitaux de Paris

Jeremy Farrar
Wellcome Trust Major Overseas Programme, OUCRU, Hospital for Tropical Diseases Viet Nam

Brian Feagan
Director of Robarts Clinical Trials
Robarts Research Institute

Dieter Felsenberg
Charité- Universitätsmedizin Berlin

Markus Feufel
Max Planck Institute for Human Development

Andreas Fibig
Chairman of the Board
Bayer Schering Pharma AG

Antoine Flahault
Ecole des hautes études en Santé Publique (EHESP)

Linda P. Fried
Columbia University Mailman School of Public Health

Philippe Froguel
Imperial College London

Keiji Fukuda
Assistant Director-General ad interim for Health Security and Environment
World Health Organization

Jens Oliver Funk
Member of the R & D Management Board, Head of Therapeutic Area Oncology
Merck Serono

Nils Gade
Director, Population Services International (PSI) - Europe
Population Services International

Wolfgang Gaissmaier
Max Planck Institute for Human Development

Edwin Gale

Bernd Gallhofer
Chairman, Head of Department
Justus Liebig University School of Medicine

Kateryna Gamazina
Ukraine Country Program Director
PATH Ukraine

Sanjiv Sam Gambhir
Director Molecular Imaging Program, Professor Department of Radiology & Bioengineering
Stanford University

Detlev Ganten
World Health Summit

Rupert Gerzer
German Aerospace Center

Tedros Adhanom Ghebreyesus
Federal Minister of Health, Ethiopia and Chair Global Fund

Gerd Gigerenzer
Max Planck Institute for Human Development

Geoffrey Ginsburg
Director, Center for Genomic Medicine
IGSP Center for Genomic Medicine

Jacques Glowinski
Honorary Administrator
Collège de France

Peter Gluckman
Centre for Human Evolution Development and Disease Liggins Institute, University of Auckland

Wim G. Goettsch
Deputy Secretary
Medicinal Products Reimbursement Committee Health Care Insurance Board (CVZ)

Michel Goldman
Executive Director
The Innovative Medicines Initiative

Peter Gondrie
Executive Director
KNCV Tuberculosis Foundation

Carl Graf Hohenthal
Brunswick Group

Jasienska Grazyna
Professor of Human Biology
Jagiellonian University

Anatoly Grigoriev
Scientific Leader of the Institute
Russian Academy of Sciences, Institute of Biomedical Problems

Peter Groenewegen
NIVEL - Netherlands Institute for Health Services Research

Hermann Gröhe
Minister of State
Federal Chancellor’s Office

Peter Gruss
Max Planck Society

Annette Grüters-Kieslich
Charite - Universitätsmedizin Berlin

Dongfeng Gu
China Academy of Chinese Medical Sciences

Hans-Christian Gunga
Charité - Universitätsmedizin Berlin

Thorsten Gutjahr
F. Hoffmann-La Roche Ltd.

Michael Haas
Law firm partner
Law firm Pöppinghaus I Schneider I Haas

Jörg Hacker
Robert Koch-Institut

Manfred Haehl
Head of Corporate Division Medicine
Boehringer Ingelheim GmbH

Eckhart G. Hahn
FACP, MME (Bern), Association of Medical Education

Victoria Hale
Founder and CEO of Medicines360, Founder and Chairman Emeritus of the Institute of One World Health
Institute for OneWorld Health

Mark Hanson
Professor of Cardiovascular Science
University of Southampton

Sigrid Harendza
Universitätsklinikum Hamburg-Eppendorf

Hans-Ulrich Häring
University Tübingen

Kristen Hawkes
University of Utah

Thomas Hegemann
Managing Partner

Nicolaus Henke
McKinsey & Company

Sebastian Herberger
Charité Medical University

Bradley Herring
Assistant Professor, Health Policy and Management
Johns Hopkins Bloomberg School of Public Health

Rainer Hess
Gemeinsamer Bundesausschuss

Arthur Higgins
Chairman, Board of Management, Bayer HealthCare AG
President of the European Federation of Pharmaceutical Industries and Associations (EFPIA)

Edward Hillhouse
University of Leeds

Peter Hintze
Parliamentary State Secretary
Federal Ministry of Economics and Technology, Germany

Liselotte Højgaard
Professor, Director, Chair of European Medical Research Council
Copenhagen University Hospital

Florian Holsboer
Max Planck Institute of Psychiatry

Bjørn Holstein
Professor in Medical Sociology
University of Copenhagen, Institute of Public Health

Matthias Holtmeyer
KPMG in Germany

Richard Horton
The Lancet

Ed Horwitz
International Society for Cellular Therapy Head Office

Hedvig Hricak
Chair Department of Radiology
Memorial Sloan - Kettering Cancer Center, New York

Peter Hufnagl
Charité Universitätsmedizin Berlin

Jochen Hurlebaus
Director Innovation Management
Roche Diagnostics

Hiroo Imura
Professor Emeritus
Kyoto University

Stefan Jähnichen
Technische Universität Berlin

Dean T. Jamison
Professor of Global Health
University of Washington

Harry L.A. Janssen
Professor of Hepatology
Erasmus MC University Hospital Rotterdam

Desmond Johnston
Imperial College London

Hans-Georg Joost
Scientific Director

Axel Kahn
Université Paris Descartes

Amir Kalali
VP Quintiles Inc and Clinical Professor of Psychiatry
University of California

Panos Kanavos
London School of Economics

Hans Karle
Past President
World Federation for Medical Education (WFME)

Vishwa Mohan Katoch
Secretary to Government of India
Department of Health Research (Ministry of Health & Family Welfare)

Hugo Katus
Department of Cardiology, University Hospital Heidelberg

Stefan Kaufmann
Max-Planck-Institute for Infection-Biology

Samer Kayal
Université Paris Déscartes

Michel Kazatchkine
Executive Director
The Global Fund To Fight AIDS, Tuberculosis and Malaria

Dermot Kelleher
Vice Provost for Medical Affairs and Head of School of Medicine
Trinity College Dublin

Hassan Khan
Aga Khan University

Ilona Kickbusch
Director Global Health Programme
The Graduate Institute of International and Development Studies Geneva

Julia Kirchheiner
Professor of Clinical Pharmacology
Institute of Pharmacology of Natural compounds and Clinical Pharmacology, University Ulm

Inga Kirsten
Charité Medical University

Michael J. Klag
Johns Hopkins Bloomberg School of Public Health

Sabine Kleinert
Senior Executive Editor
The Lancet

Hartmut Kolb
Vice President, Molecular Imaging Biomarker Research
Siemens Medical Solutions USA, Inc.

Ewa Kopacz
Ministry of Health Poland

Bernard Kouchner
French Minister of Foreign Affairs and European Affairs

Inessa Kozlovskaya
Deputy Director
IBMP Moscow

Werner Kramer
Vice-President Discovery Research Diabetes, Head of R&D Germany
sanofi-aventis Deutschland GmbH

Heyo K. Kroemer
Chairman, Department of Pharmacology, Dean Medical School
Ernst-Moritz-Arndt-University Greifswald

Arno Krotzky
metanomics Health GmbH

Anant Kumar
Chief Executive Officer
LifeSpring Hospitals Pvt. Ltd

Bärbel-Maria Kurth
Head of the Department for Epidemiology and Health Reporting
Robert Koch Institute

Mylinh La
Pharmacology, Senior Research Fellow
Monash University

Markku Laakso
University of Kuopio

Antoine Lafont
Université Paris Descartes

Christian Lahm
Lahm & Partner I Health Politics - Media - Expertise

Astrid Langer
Chair of Institute of Health Economics and Health Care Management
Ludwig-Maximilian University Munich

Vladimir Lazarevik
Health Policy Expert and Lecturer
Skopje University

Anne-Laurence Le Faou
Senior Lecturer in Public Health, PhD in Economics, Head of the Tobacco Cessation Center
Hôpital Européen Georges Pompidou

Thomas Lee
Professor and Network President
Harvard Medical School and Partners Healthcare

Andreas Lendlein
Director of Institute of Polymer Research, Vicepresident BCRT
GKSS-Forschungszentrum Geesthacht GmbH in Teltow

William Leonard
Professor of Anthropology
Northwestern University

Christopher O. Leonards
Center for Stroke Research Berlin, Charité Medical University

Achim Leutz
Head of Research Group Cell Differentiation and Tumorgenesis

Klaus Lindpaintner
F. Hoffmann-La Roche Ltd.

Peter Littlejohns
Clinical and Public Health, National Institute for Health and Clinical Excellence (NICE)

Denis Yu Logunov
Senior Scientist Molecular Biotechnology
Russian Academy of Medical Sciences

Martin Lohse
Chairman of the Rudolf Virchow Center
University Würzburg

Ellen MacKenzie
Fred and Julie Soper Professor and Chair of Health Policy and Management
Johns Hopkins Bloomberg School of Public Health

Hans Maier
Head of Business Unit Diagnostic Imaging
Bayer Schering Pharma AG

Davide Manissero
Tuberculosis Programme Coordinator

Ulrike Maschewsky-Schneider
Programm Coordinator
Berlin School of Public Health at the Charité

Richard McFarland
"U.S. Department of Health and Human Services, U.S. Food and Drug Administration "

Martin McKee
Professor of European Public Health
London School of Hygiene and Tropical Medicine and European Observatory on Health Systems and Policies

John McNeil
Head of School
Monash University

David Medina
Director, WW Life Sciences Segment
Hewlett-Packard Company

Christian Meisel
F. Hoffmann-La Roche Ltd.

Joël Ménard
Paris Descartes University

Georgyi Mentkevich
Deputy Director
Russian Cancer Research Center, Russian Academy of Medical Science

Mark Miller
Director, Division of International Epidemiology and Population Studies
Fogarty International Center, National Institutes of Health

Thomas Miller
CEO Workflow & Solutions Division
Siemens AG Healthcare Sector

Anne Mills
Professor of Health Economics and Policy, Head, Department of Public Health and Policy
London School of Hygiene and Tropical Medicine (University of London)

Tomica Milosavljevic
Ministry of Health Serbia

Masao Mitsuyama
Kyoto University Graduate School of Medicine

Jürgen Mlynek
Helmholtz-Gemeinschaft Deutscher Forschungszentren

Festus Gontebanye Mogae
Former President of Botswana

Judith A. Monroe
State Health Commissioner
Indiana State Department of Health

Luc Montagnier
World Foundation AIDS Research and Prevention

Rolf D. Müller
Chairman of the AOK Berlin

Jacqueline Müller-Nordhorn
BSPH, Fachgebiet Public Health / Epidemiologie
Charité – Universitätsmedizin Berlin

Trevor Mundel
Global Head of Development Pharma
Novartis Pharma AG

Phillip Musgrove
Deputy Editor
Health Affairs

Kazuwa Nakao
Translational Research Center and EBM Research Center, Kyoto Graduate School of Medicine

Leila S. Namazova
Vice President
Scientific Center of Children’s Health

Shuh Narumiya
Professor of Pharmacology
Kyoto University Graduate School of Medicine

Maria Neira
Director, Public Health and Environment
World Health Organization

Randolph Nesse
Director, Evolution and Human Adaptation Program
The University of Michigan

Angus Nicoll
Senior Expert - Influenza Coordination
European Center for Disease Prevention and Control

Pierluigi Nicotera
PHD, Director
German Center for Neurodegenerative Diseases

Vyacheslav Novitskiy
Siberian State Medical University

Bujar Osmani
Ministry of Health, Macedonia

Valérie Pécresse
French Minister
Ministry of Higher Education & Research, France

Andreas Penk
President Oncology Europe & Country Lead Germany

Richard Peto
Professor of Medical Statistics
Clinical Trial Unit Oxford

Barbara Pfüller
Clinical Development & Regulatory Affairs
Berlin-Brandenburg Centre for regenerative Therapy

Jan Pietzsch
Consulting Assistant Professor
Stanford University/WingTec GmbH

Peter Piot
Director, Institute for Global Health
Imperial College London

Leon Piterman
Senior Deputy Dean
Monash University

Wolfgang Plischke
Chairman of the Board, German Association of Research-based Pharmaceutical Companies (vfa)
Member of the Board of Management, Bayer AG

Ysbrand Poortman
Vice President WAO and Secretary IGA
World Alliance of Organization for the Prevention and Treatment of Genetic Conditions, Washington

Cornelia Quennet-Thielen
Federal Ministry of Education and Research, Germany

Rino Rappuoli
Global Head Vaccines Research
Novartis Vaccines and Diagnostics

Philippe Ravaud
Head of Department
Paris Descartes University

Olivier Raynaud
Senior Director
World Economic Forum

Vera Regitz-Zagrosek
Institute Director
Charite, Universitätsmedizin Berlin

Erich Reinhardt
Former CEO Healthcare Sector
Siemens AG

Uwe E. Reinhardt
Professor of Economics and Public Affairs
Princeton University

Petra Reinke
Nephrologist, Leader BCRT Platform Immunology and Cell Therapy
Charité - Universitätsmedizin Berlin

Thomas Reiter
Astronaut, Member Executive Board of the DLR
German Aerospace Center (DLR)

Hermann Requardt
Siemens AG Healthcare Sector

John W. Reuter
GEOSCIENCE Support Services, Inc.

Andreas Rickert
Bertelsmann Stiftung

Ernst Th. Rietschel
Leibniz Association

Mary Robinson
GAVI Alliance

Michael Roden
Scientific Chief Executive Director
German Diabetes Center

Leonid M. Roshal
Emergency Children's Surgery Institute and Trauma

Hans Rosling
Gapminder Foundation

Alexander Rumyantsev
Director, Head of Pediatric Chair
Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of the Russian Federation

John-F Ryan
Head of Unit Health threats
European Commission DG SANCO

Philippe Sansonetti
Professor at the Collège de France
Professor at Institut Pasteur

Alexander Schachinger
Doktorand Zukunft digitaler Healthcare Kommunikation
Humboldt Universität Berlin

Annette Schavan
Federal Minister
Federal Ministry of Education and Research, Germany

Sophia Schlette
Senior Expert Health Policy
Bertelsmann Foundation

Norbert Schmacke
Coordinating Department for Health Research
University of Bremen

Harald Schmidt
Monash University

Ulla Schmidt
Federal Ministry of Health

Jürgen Schölmerich
Vice President of the German Research Foundation (DFG)
University of Regensburg

Klaus Theo Schröder
State Secretary
Federal Ministry of Health

Matthias Schwab
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology

Markus Schwaiger
Chairman Department of Nuclear Medicine
Technical University of Munich

Reinhard Schweppe
Permanent Mission of Germany to the U.N.

Jürgen Schwiezer
CEO Division Roche Diagnostics & Member of the Executive Committee
F. Hoffmann-La Roche AG

Peter Scriba
University of Munich

Robert Sebbag
Vice-President Access to Medicines

Werner Seeger
Scientific Council
University of Giessen

Marylou Selo
Werner Alfred Selo Stiftung

Peter Sever
Professor of Clinical Pharmacology and Therapeutics
International Centre for Circulatory Health, Imperial College London

Alexander Shabrov
St.-Petersburg State Mechnikov Medical Academy

Evgeny Sidorenko
Russian State Medical University

Cornel Sieber
Head of Medical Clinic 2, Head of Institute for Biomedical Aging FAU Erlangen-Nürnberg
Klinikum Nürnberg Nord

Detlef S. Siewert
Business Director / Leader Global Health Europe/ Middle East/ Africa
BD Diagnostics - Diagnostic Systems

Gregory Simon
Senior Vice President Global Policy
Pfizer Inc.

Ian Smith
Deputy Dean
Monash University

Stephen Smith
Principal of the Faculty of Medicine/CEO
Imperial College Lodnon

Paul Sommerfeld
Action for Global Health, and TB Alert

Janice Soreth
Deputy Director
Europe Office, US Food and Drug Administration

Giorgio Stanta
University of Trieste

Dan Stein
University of Cape Town

Donald Steinwachs
Professor, Health Policy and Management
Johns Hopkins Bloomberg School of Public Health

Philipp Sterzer
Junior Research Group Leader
Charite - Universitätsmedizin Berlin

Günter Stock
Berlin-Brandenburg Academy of Sciences

Victor Strecher
Chief Visionary Officer

Jaap Suermondt
Hewlett-Packard Company (HP Labs)

John Sulston
Institute for Science, Ethics and Innovation, University of Manchester

Peter Suter
Swiss Academy of Medical Sciences

André Syrota
Chairman and CEO
Institut national de la santé et de la recherche médicale (INSERM)

Makoto Mark Taketo
Vice Dean
Kyoto University Graduate School of Medicine

Rudolf Tauber
Vice-Dean of Research
Charité - Universitätsmedizin Berlin

Jens Titze
University of Erlangen

Alfonso Troisi
Professor of Psychopathology
University of Rome Tor Vergata

Carsten Tschöpe
Cardiologist, Leader BCRT Platform Cardiovascular System
Charité – Universitätsmedizin Berlin

May Tsung-Mei Cheng
Princeton University

Amin T. Turki
Medical University Munster and Harvard University

Willemien Van de Water
Leiden University Medical Centre

James Vaupel
Max-Planck-Institute for Demographic Research

Cesar G. Victora
Professor of Epidemiology
Federal University of Pelotas

Christopher A. Viehbacher

Pascal Villeneuve
Associate Director
Programme Division (Programme Partnerships) UNICEF

Hans Dieter Volk
Director BCRT
Charité- Universitätsmedizin Berlin

Nikolai Nikolaevish Volodin
Academician of the RAMS, Rector
Russian State Medical University Moscow

Erika von Mutius
Professor of Pediatrics
University Children’s Hospital Munich

Melanie Wakefield
Director, Centre for Behavioural Research in Cancer
The Cancer Council Victoria

Euan Wallace
Professor of Obstetrics and Gynaecology, Director of Obstetric Services, Southern Health
Monash University

Paul J. Wallace
Medical Director for Health and Productivitiy Management Programs
The Permanente Federation, Kaiser Permanente

Mark Walport
The Wellcome Trust

Beat Walpoth
Director, Cardiovascular Research, Clinic and Experimental President
European Society for Artificial Organs (ESAO), University Hospital Geneva

Michael Warmbold
Vice President Medical

Steven A. Wartman
Association of Academic Health Centers

Jürgen Wasem
Director, Chair for Health Services Management
University of Duisburg-Essen

Odette Wegwarth
Max Planck Institute for Human Development

Sonja Weinreich
Senior Health Advisor
Church Development Service

Steve Wesselingh
Faculty of Medicine Nursing & Health Sciences, Monash University

Otmar Wiestler
Chairmen of the Board
German Cancer Research Center (DKFZ)

Bryan Williams
Monash Insitute of Med. Research, Monash University

Stefan N. Willich
Director Institute of Social Medicine, Epidemiology and Health Economics
Charité - Universitätsmedizin Berlin

Stefan Winter
Member of the Board and Chief Medical Officer
CompuGROUP Holding AG

Jürgen Wolf
University Hospital Cologne

John E. L. Wong
Deputy Chief Executive / Dean, Yong Loo Lin School of Medicine
National University of Singapore, National University Health System

Klaus Wowereit
Governing Mayor of Berlin

Henning Wrogemann

Floris Wuyts
Head for University Research for Equilibrium and Aerospace
University of Antwerp

Motoko Yanagita
Kyoto University Graduate Sool of Medicine

Pedro Yrigoyen
Co-Founder, Head International Business Development
Medical Home

Risards Zaleskis
Regional Adviser, Tuberculosis Control
WHO Regional Office for Europe

Fanyi Zeng
Associate Director
Shanghai Jiao Tong University School of Medicine

Elias Zerhouni
Former Director
US National Institutes of Health

Xue Zhang
China Academy of Chinese Medical Sciences

Zhenxin Zhang
Peking Union Medical College & Chinese Academy of Medical Sciences

Qi Zhou
Assistant Director
Institute of Zoology, Chinese Academy of Sciences

Harald zur Hausen
German Cancer Research Center (DKFZ)

Jürgen Zurheide
Independent Journalist

Vitaly Zverev
Russian Academy of Medical Sciences